The business of clinical trials is booming. Private equity has taken notice.

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry's more hidden niches: They are pouring billions into the business of clinical drug trials.

source https://www.news-medical.net/news/20221202/The-business-of-clinical-trials-is-booming-Private-equity-has-taken-notice.aspx

Comments

Post a Comment

Popular posts from this blog

New and surprising evidence that ChatGPT can perform several intricate tasks relevant to handling complex medical and clinical information

Researchers evaluated the performance of an AI model named ChatGPT to perform clinical reasoning on the United States Medical Licensing Exam (USMLE). source https://www.news-medical.net/news/20230213/New-and-surprising-evidence-that-ChatGPT-can-perform-several-intricate-tasks-relevant-to-handling-complex-medical-and-clinical-information.aspx
Read more

"Deep sequencing" of the genome informs diagnoses and treatment of vascular anomalies

Researchers from Children's Hospital of Philadelphia (CHOP) recently discovered that extremely thorough "deep sequencing" of the genome in tissue samples and cell-free DNA of patients with potentially life-threatening vascular anomalies captured several genetic variants related to disease that were not captured with conventional genetic sequencing methods. source https://www.news-medical.net/news/20230601/Deep-sequencing-of-the-genome-informs-diagnoses-and-treatment-of-vascular-anomalies.aspx
Read more